Continuous Glucose Monitoring

Latest papers

17 papers2 papers in the last four weeks, down 33% on the four weeks before. 0.0% of all new papers.

Nov 13, 2026

Identification and external validation of the sets of 4-, 6-, 8-, 12-, and 24-hour CGM motifs

There is growing interest in using CGM for purposes other than those initially intended. Recent work of Lobo et al. identified ΩΩ: a set of motifs such that almost any daily CGM profile (the 24-hour CGM time series starting at midnight) can be classified - matched to a motif in ΩΩ. This work generalizes the prior work by identifying sets of motifs for 4-, 6-, 8-, 12-, and 24-hr CGM profiles where an xx-hr CGM profile does not have to be 24 hours in length, and does not have to start at midnight. The prior work methods are modified to identify the five new sets of motifs using data from the same 6 studies in the original work. The newly identified sets were subjected to rigorous external validation using a data set comprised of data from 21 studies (3,455 subjects, 289,592 days of CGM data). The external validation data set has both temporal and geographic transportability and addresses limitations of the data set used to define the five new sets of motifs. The results of the external validation indicate that the prior work generalizes well: the performance of each xx-hr set of motifs on the external validation set is almost identical to that obtained for ΩΩ. The generalization of the original work broadens the potential use cases of the framework to include short term predictions (e.g., impending hypoglycemia) and diagnostics which rely on detecting changes in CGM time series which are less than 24 hours in length.
Oct 26, 2026

Reliability-Aware Short-Term Glycemic Risk Prediction Using an Anchor-Based Comparative Framework of Sequence, Multimodal, and State-Updating Digital-Twin Models

Anticipating short-term hypoglycemic and hyperglycemic risk is essential for proactive diabetes management. However, existing machine learning approaches often use inconsistent evaluation protocols and emphasize predictive performance over reliability. This study introduces an anchor-based benchmarking framework integrating longitudinal glucose sequences and multimodal patient information. Using the T1DiabetesGranada dataset, 5,503,441 standardized prediction anchors were constructed from 736 individuals with type 1 diabetes to evaluate hypoglycemia and hyperglycemia prediction at 30-, 60-, and 120-minute horizons. Three neural architectures, a Hybrid LSTM-Transformer, a Multimodal Digital Twin, and a State-Updating Digital Twin with gap-aware longitudinal state progression, were compared under identical patient-level validation protocols. Beyond predictive performance, the evaluation examined calibration, classification thresholds, explanation reliability, cross-model disagreement, and robustness to controlled perturbations. No statistically significant predictive differences were observed after Holm correction, although the models exhibited complementary reliability characteristics. The Multimodal Digital Twin achieved the lowest mean Brier score, while the State-Updating Digital Twin demonstrated the lowest mean expected calibration error (ECE-10). The Hybrid LSTM-Transformer showed strong explanation faithfulness and stability under its temporal attribution protocol. These findings highlight the importance of evaluating digital-twin models beyond predictive accuracy and emphasize the need for reliability assessment and external validation before clinical deployment.
Oct 8, 2026

GlucoPRISM: Protocol-Supervised Pretraining for Cross-Cohort Glucose Transfer

Continuous glucose monitoring (CGM) foundation models encode each day as one vector that mixes who the person is, what happened that day and how the sensor measured it, so measurement differences travel with the representation into new cohorts. We ask whether pretraining can place the measurement component that harms transfer in known coordinates, so that deployment drops them with a fixed projection and no target data. GlucoPRISM supervises a GlucoFM backbone with response contracts, rules for how each part of the representation should change when only the day or only the sensor changes: a 64-dimensional Trait band should change with neither, a 48-dimensional State band only across days, and a 16-dimensional Sensor band should track the device. Synthetic sensor views calibrated on paired Dexcom and Libre recordings, different-day pairs and glucose-summary targets supply this supervision without clinical labels. Across twelve cross-cohort directions, dropping the Sensor band from the same frozen encoder raises mean transfer AUROC from 68.75 to 73.57, against 69.3 for GlucoFM. The gain has two parts. Into CGMacros, the one target cohort recorded with two sensor types, filtering adds 11 to 19 points, and this holds when the generator is recalibrated on half of the participants and scored on the other half. On the other eight directions filtering is neutral and the encoder itself exceeds GlucoFM by 3.5 points. The device remains linearly decodable after filtering, so the filter removes a device-related component that harms transfer rather than all measurement information. The retained bands improve window AUROC on thirteen of fourteen public task--cohort cells (Holm-adjusted p=0.031) and correlation on fourteen of fifteen clinical endpoints in an external cohort of 9,303 participants.
Sep 30, 2026

RACE: Residual-Aware Test-Time Adaptation for Neighbor-Rich Time-Series Foundation Model Forecasting

Time-series foundation models (TSFMs) perform strongly across forecasting tasks, but their per-series inference is ill-suited to neighbor-rich forecasting, where each query has access to related but nonidentical historical series. Continuous glucose monitoring (CGM) and Web/cloud workloads exemplify this setting: CGM trajectories share physiological patterns but vary across individuals, devices, and conditions, while Web/cloud workloads combine common operating regimes with non-stationarity, heavy tails, and bursts. These histories share useful structure, yet neighbors are not equally relevant. Existing methods either fine-tune TSFMs for each target domain, incurring additional costs and offering limited transferability across backbones, or append retrieved series without verifying whether they support the current forecast. The key challenges are conflicting residual evidence from neighboring series and residual patterns that vary across TSFMs and forecasting tasks. We formulate test-time neighborhood scaling: using same-domain neighbor evidence without modifying the backbone. We propose RACE (Residual-Aware Correction of Forecasting Errors), a two-stage framework for using historical neighbors. We first retrieve query-compatible neighbors, align their residuals to the query scale, and aggregate coherent evidence into the training-free RACE-TF correction. Full RACE then uses a lightweight, domain-specific Gate to determine when applying the correction is beneficial, with a reusable training workflow across TSFM backbones. Across four TSFMs, RACE improves all three domain-aggregate metrics on both primary domains, with the largest gains on high-error queries. Within each domain, a Gate trained on one TSFM transfers to other backbones without adaptation, and the resulting pipeline improves all 72 cross-backbone metric comparisons over the matched frozen targets.
Sep 23, 2026

Transferable Evidence Reconstruction for Longitudinal Glucose Representations

Long physiological recordings contain many routine measurements, while predictive information often lies in rare events, sustained burden, and recurring patterns. These properties can be computed as label-free evidence, but directly using them as features leaves limited labeled data to separate reproducible associations from sample-specific ones. Learning to reconstruct evidence can exploit unlabeled recordings, yet joint reconstruction does not explicitly require the decoding rule to transfer across individuals. We introduce transferable evidence reconstruction (TER): a Ridge regressor fits evidence from representations in one group and predicts it in an identity-disjoint group without refitting. The transfer error trains the encoder through the differentiable fit. For continuous glucose monitoring (CGM), clock-aware encoding preserves the multi-day content and timing needed for evidence recovery. Matched interventions connect the gains to reduced fitting-group sensitivity, with structured targets improving on raw recovery. Across ten leading CGM and time-series baselines, TER sets a new best metric on 12/14 phenotype tasks and exceeds the strongest prior overall PR-AUC/ROC-AUC/Macro-F1 by 4.95/4.43/0.66 percentage points; the PR-AUC and ROC-AUC gains are 2.6×2.6\times and 2.2×2.2\times the respective gaps between the two strongest baselines. Meal-response and future-CGM studies further demonstrate predictive utility. TER thus uses meaningful signal properties to supervise not only what a representation preserves, but how reliably it can be read across individuals.
Sep 10, 2026

Evaluating Time-Series Foundation Models and Multimodal Dietary Context for CGM Forecasting

Continuous glucose monitoring (CGM) provides high-frequency measurements of glucose dynamics and enables short-term glucose forecasting for diabetes management. Although time-series foundation models have shown strong general forecasting ability, their effectiveness for CGM prediction and the added value of multimodal dietary context remain unclear. We conduct a comprehensive empirical study using eight public CGM datasets spanning Type 1 diabetes, Type 2 diabetes, and non-diabetes populations. Under a unified protocol across multiple context lengths and prediction horizons, zero-shot foundation models did not consistently outperform strong task-specific baselines such as Elastic Net and PatchTST. In contrast, lightweight fine-tuning substantially improved forecasting performance. For example, fine-tuned Chronos-Bolt reduced RMSE by 6.5%-18.4% in the T1D cohort and by 8.6%-18.2% in the non-diabetes/T2D cohort, with comparable improvements in both in-distribution and out-of-distribution test settings. We further evaluate multimodal dietary context using CGMacros, which provides temporally aligned CGM signals, food images, and macronutrient records. A residual-based fusion framework reduced overall RMSE by approximately 3% and postprandial RMSE by approximately 15% relative to the CGM-only baseline. Moreover, Chronos-based CGM representations were more strongly correlated with observed postprandial glucose increments than representations from LSTM and CatBoost, even after those models incorporated additional dietary modalities, suggesting that pretrained temporal representations better preserve meal-induced excursion patterns. These findings show that foundation models require CGM-specific adaptation for reliable forecasting and that dietary context provides clinically meaningful signals beyond CGM alone, especially during postprandial periods.
Aug 18, 2026

FairGlucose: A CGM Fairness Benchmark Reveals Subgroup Disparities Hidden in Population-Level Validation

As CGM-based AI tools approach clinical deployment, whether their accuracy is equitable across patient demographics remains insufficiently tested. To enable this evaluation, we constructed FairGlucose, a 300-patient CGM cohort balanced across 12 demographic strata (age x gender x type 1/type 2 diabetes), with 132,480 forecasting samples and 3,945 unique behavioral events (meals, exercise, medication) logged by 81 patients. Benchmarking 33 models across four families on 2-hour glucose forecasting, we find that population-level external validation can conceal substantial subgroup disparities. Aggregate out-of-distribution metrics appear stable (approximately 1.0), yet subgroup-level ratios range from 0.8 to 1.4, with T1D patients showing 6 mg/dL higher prediction error than T2D (p < 0.001). This disparity persists across all 33 models, suggesting a property of the prediction task rather than any single architecture. Further analysis shows that subgroup performance gaps align with the proportion of clinically hard cases, and that input-length sensitivity varies across demographics, motivating personalized configurations. Frontier LLMs underperform specialized neural models by 1-6 mg/dL; behavioral events contribute negligibly (approximately 0.1 mg/dL) even under oracle event access. These findings establish that population-level validation alone is insufficient for equity assessment of digital health AI, motivating subgroup-disaggregated reporting as a default standard.
Jun 17, 2026

MetaboNet-Bench: A Multi-modal Benchmark for Glucose Forecasting in Type 1 Diabetes

Glucose forecasting algorithms are an important aspect of glycemic control management in type 1 diabetes. So far, the research community has developed numerous algorithms and models for forecasting. However, it is well-recognized that the lack of standardized model performance evaluation benchmarks makes fair comparison difficult and hinders further innovation, and thus benchmark standardization is in urgent need. Furthermore, many published glucose forecasting algorithms are limited to CGM data alone, ignoring other multimodal signals such as insulin dosing and carbohydrate intake. Here, we introduce MetaboNet-Bench, a benchmark for multimodal glucose forecasting for patients with type 1 diabetes that provides an extensible open-source evaluation framework for comparison of glucose forecasting algorithms that leverage glucose, insulin, and carbohydrate data. We then demonstrate its utility by benchmarking several recently published glucose forecasting models and a custom multimodal time-series model, representing different model architectures. The results show that the benefit of adding data modalities is conditioned on the complexity of the model and that incorporating more clinical metrics helps identify meaningful gaps to fill for future research.
Jun 14, 2026

An Exploratory Study of Blood Glucose Estimation from Photoplethysmography Signals using Machine Learning

Diabetes and extreme blood sugar levels are some of the major health problems faced by humans today across the world. While Continuous Glucose Monitoring (CGM) has emerged as an effective technology for management of diabetes as well as for monitoring blood sugar levels, this technology has traditionally been invasive (that is, requiring the piercing of the skin) and carries the risk of irritation, induration, etc. This highlights the need for accurate and non-invasive CGM methods that can be deployed at scale. With the emergence of various sensing technologies and their integration in wearables like the smart-watch, we now have the capability to continuously monitor body signals like the Photoplethysmogram (PPG) in a non-invasive manner. Having the ability to continuously monitor blood glucose through CGMs and continuously monitor PPG signals through a smart-watch offers an opportunity to get dense data on these two, opening the possibility of building machine learning and deep learning based models to estimate blood glucose level from PPG signals. In this work, we first present a paired dataset comprising continuous PPG signals from a smartwatch along with glucose values recorded using a CGM device. We also present the results of some preliminary experimental explorations performed on our dataset. These preliminary results suggest that some predictive signals may exist, though more exploration is needed with more data from a larger number of individuals. The dataset can be accessed at https://zenodo.org/records/20577959
May 29, 2026

GlucoFM: A Dual-Stream Foundation Model for Continuous Glucose Monitoring

Continuous glucose monitoring (CGM) provides a dense view of daily metabolic physiology, yet existing generic time-series and CGM-specific foundation models often encode glucose traces as entangled single-stream sequences, leaving the distinct temporal structure of glycemic dynamics only implicitly modeled. We present GlucoFM, a lightweight CGM foundation model that aligns irregular recordings to a 24-hour chronological grid, preserves observation masks, and decomposes glucose dynamics into slow physiological state and transient event streams, capturing low-frequency glycemic baselines and short-term deviations that may reflect acute physiological responses or sensor artifacts. GlucoFM is pretrained on 109,066 hours of unlabeled CGM recordings from 477 subjects with two complementary objectives: masked contextual latent prediction over fused daily representations and temporal dynamics prediction over state and event streams. Across four diverse cohorts and seven clinical prediction tasks, GlucoFM achieves the strongest subject-disjoint linear-probing performance among evaluated baselines, improving average PR-AUC by 4.1 points over the best CGM-specific foundation model. Its gains are most pronounced on core metabolic outcomes, leading PR-AUC on all diabetes-risk and ββ-cell dysfunction tasks and on 3 of 4 insulin-resistance tasks. GlucoFM also achieves the best overall cross-dataset transfer performance and strong few-shot adaptation among evaluated methods, and consistent gains when aggregating multiple days for subject-level prediction, highlighting physiology-aware decomposition as an effective inductive bias for transferable CGM representation learning.
May 1, 2026

CGM-JEPA: Learning Consistent Continuous Glucose Monitor Representations via Predictive Self-Supervised Pretraining

Continuous Glucose Monitoring (CGM) can detect early metabolic subphenotypes (insulin resistance, IR; ββ-cell dysfunction), but population-scale deployment faces two coupled problems. First, the same physiological state appears through multiple views (CGM time series, venous OGTT, Glucodensity summaries), so single-view representations fail to transfer when deployment shifts the modality or setting. Second, baselines perform inconsistently across these shifts. Both problems point to one remedy: representations that abstract away from any single view to capture higher-level temporal and distributional structure. We propose CGM-JEPA, a self-supervised pretraining framework which predicts masked latent representations rather than raw values, yielding abstraction that transfers across modalities. X-CGM-JEPA adds a masked Glucodensity cross-view objective for complementary distributional information. We pretrain on ∼\sim389k unlabeled CGM readings from 228 subjects and evaluate on two clinical cohorts (N=27N=27 and N=17N=17 public-release subsets) across three regimes (cohort generalization, venous-to-CGM transfer, home CGM) under 20-iteration ×\times 2-fold cross-validation. X-CGM-JEPA ranks first or second on AUROC for both endpoints across all three regimes while no baseline does, exceeding the strongest baseline by up to +6.5+6.5 pp in cohort generalization and +3.6+3.6 pp in venous-to-CGM transfer (paired Wilcoxon, p<0.001p<0.001). Under modality shift, it matches mean AUROC while redistributing toward weaker subgroups (ethnicity AUROC gap shrinks 25-54%); on sparse in-domain venous data, the distributional view lifts label-aware clustering (ARI +39%+39\%, NMI +40%+40\%). Code and weights: https://github.com/cruiseresearchgroup/CGM-JEPA
Apr 18, 2026

If Only My CGM Could Speak: A Privacy-Preserving Agent for Question Answering over Continuous Glucose Data

Continuous glucose monitors (CGMs) used in diabetes care collect rich personal health data that could improve day-to-day self-management. However, current patient platforms only offer static summaries which do not support inquisitive user queries. Large language models (LLMs) could enable free-form inquiries about continuous glucose data, but deploying them over sensitive health records raises privacy and accuracy concerns. In this paper, we present CGM-Agent, a privacy-preserving framework for question answering over personal glucose data. In our design, the LLM serves purely as a reasoning engine that selects analytical functions. All computation occurs locally, and personal health data never leaves the user's device. For evaluation, we construct a benchmark of 4,180 questions combining parameterized question templates with real user queries and ground truth derived from deterministic program execution. Evaluating 6 leading LLMs, we find that top models achieve 94% value accuracy on synthetic queries and 88% on ambiguous real-world queries. Errors stem primarily from intent and temporal ambiguity rather than computational failures. Additionally, lightweight models achieve competitive performance in our agent design, suggesting opportunities for low-cost deployment. We release our code and benchmark to support future work on trustworthy health agents.
Apr 16, 2026

Blinded Multi-Rater Comparative Evaluation of a Large Language Model and Clinician-Authored Responses in CGM-Informed Diabetes Counseling

Continuous glucose monitoring (CGM) is central to diabetes care, but explaining CGM patterns clearly and empathetically remains time-intensive. Evidence for retrieval-grounded large language model (LLM) systems in CGM-informed counseling remains limited. To evaluate whether a retrieval-grounded LLM-based conversational agent (CA) could support patient understanding of CGM data and preparation for routine diabetes consultations. We developed a retrieval-grounded LLM-based CA for CGM interpretation and diabetes counseling support. The system generated plain-language responses while avoiding individualized therapeutic advice. Twelve CGM-informed cases were constructed from publicly available datasets. Between Oct 2025 and Feb 2026, 6 senior UK diabetes clinicians each reviewed 2 assigned cases and answered 24 questions. In a blinded multi-rater evaluation, each CA-generated and clinician-authored response was independently rated by 3 clinicians on 6 quality dimensions. Safety flags and perceived source labels were also recorded. Primary analyses used linear mixed-effects models. A total of 288 unique responses (144 CA and 144 clinician) generated 864 ratings. The CA received higher quality scores than clinician responses (mean 4.37 vs 3.58), with an estimated mean difference of 0.782 points (95% CI 0.692-0.872; P<.001). The largest differences were for empathy (1.062, 95% CI 0.948-1.177) and actionability (0.992, 95% CI 0.877-1.106). Safety flag distributions were similar, with major concerns rare in both groups (3/432, 0.7% each). Retrieval-grounded LLM systems may have value as adjunct tools for CGM review, patient education, and preconsultation preparation. However, these findings do not support autonomous therapeutic decision-making or unsupervised real-world use.
Apr 13, 2026

A unified data format for managing diabetes time-series data: DIAbetes eXchange (DIAX)

Diabetes devices, including Continuous Glucose Monitoring (CGM), Smart Insulin Pens, and Automated Insulin Delivery systems, generate rich time-series data widely used in research and machine learning. However, inconsistent data formats across sources hinder sharing, integration, and analysis. We present DIAX (DIAbetes eXchange), a standardized JSON-based format for unifying diabetes time-series data, including CGM, insulin, and meal signals. DIAX promotes interoperability, reproducibility, and extensibility, particularly for machine learning applications. An open-source repository provides tools for dataset conversion, cross-format compatibility, visualization, and community contributions. DIAX is a translational resource, not a data host, ensuring flexibility without imposing data-sharing constraints. Currently, DIAX is compatible with other standardization efforts and supports major datasets (DCLP3, DCLP5, IOBP2, PEDAP, T1Dexi, Loop), totaling over 10 million patient-hours of data. https://github.com/Center-for-Diabetes-Technology/DIAX
Feb 17, 2026

The Stationarity Bias: Stratified Stress-Testing for Time-Series Imputation in Regulated Dynamical Systems

Time-series imputation benchmarks employ uniform random masking and shape-agnostic metrics (MSE, RMSE), implicitly weighting evaluation by regime prevalence. In systems with a dominant attractor -- homeostatic physiology, nominal industrial operation, stable network traffic -- this creates a systematic Stationarity Bias: simple methods appear superior because the benchmark predominantly samples the easy, low-entropy regime where they trivially succeed. We formalize this bias and propose a Stratified Stress-Test that partitions evaluation into Stationary and Transient regimes. Using Continuous Glucose Monitoring (CGM) as a testbed -- chosen for its rigorous ground-truth forcing functions (meals, insulin) that enable precise regime identification -- we establish three findings with broad implications:(i)~Stationary Efficiency: Linear interpolation achieves state-of-the-art reconstruction during stable intervals, confirming that complex architectures are computationally wasteful in low-entropy regimes.(ii)~Transient Fidelity: During critical transients (post-prandial peaks, hypoglycemic events), linear methods exhibit drastically degraded morphological fidelity (DTW), disproportionate to their RMSE -- a phenomenon we term the RMSE Mirage, where low pointwise error masks the destruction of signal shape.(iii)~Regime-Conditional Model Selection: Deep learning models preserve both pointwise accuracy and morphological integrity during transients, making them essential for safety-critical downstream tasks. We further derive empirical missingness distributions from clinical trials and impose them on complete training data, preventing models from exploiting unrealistically clean observations and encouraging robustness under real-world missingness. This framework generalizes to any regulated system where routine stationarity dominates critical transients.
Jan 8, 2026

GlyRAG: Context-Aware Retrieval-Augmented Framework for Blood Glucose Forecasting

Accurate blood glucose forecasting using continuous glucose monitoring (CGM) data can support the early prediction of dysglycemic risk. However, current neural-network-based forecasting models treat CGM data as a purely numerical sequence without integrating the contextual information contained in CGM signal morphology. Recently, large language models (LLMs) have shown promise for time-series forecasting, yet their role as agentic context extractors in diabetes care remains largely unexplored. In this study, we bridge glucose forecasting and LLM-based contextualization by developing GlyRAG, a context-aware, retrieval-augmented forecasting framework that uses an LLM as a contextualization agent to summarize glucose morphology directly from a timed CGM window. The generated CGM-only narrative is embedded and fused with patch-based glucose representations, while a retrieval module incorporates similar historical training episodes through cross-attention. We evaluate GlyRAG on the OhioT1DM and AZT1D datasets for 5-, 30-, and 60-minute forecasting horizons. Compared with strong CGM-only baselines, GPT-4 GlyRAG significantly improves long-horizon root mean square error (RMSE) over PatchTST on both datasets. For example, RMSE decreases from 13.8 to 10.6 at 30 minutes and from 23.1 to 20.2 at 60 minutes on OhioT1DM. LLaMA 3.1 produces smaller but significant long-horizon gains, suggesting that the contextualization pipeline is not limited to GPT-4. Clinical error-grid analyses further show that approximately 85 percent of predictions fall within the clinically acceptable Clarke Error Grid Zones A and B. These results suggest that CGM-derived linguistic context and case-based retrieval can improve long-horizon glucose forecasting without requiring additional sensing modalities.
Jul 18, 2025

Glucose-ML: A collection of longitudinal diabetes datasets for development of robust AI solutions

Artificial intelligence (AI) algorithms are a critical part of state-of-the-art digital health technology for diabetes management. Yet, access to large high-quality datasets is creating barriers that impede development of robust AI solutions. To accelerate development of transparent, reproducible, and robust AI solutions, we present Glucose-ML, a collection of 10 publicly available diabetes datasets, released within the last 7 years (i.e., 2018 - 2025). The Glucose-ML collection comprises over 300,000 days of continuous glucose monitor (CGM) data with a total of 38 million glucose samples collected from 2500+ people across 4 countries. Participants include persons living with type 1 diabetes, type 2 diabetes, prediabetes, and no diabetes. To support researchers and innovators with using this rich collection of diabetes datasets, we present a comparative analysis to guide algorithm developers with data selection. Additionally, we conduct a case study for the task of blood glucose prediction - one of the most common AI tasks within the field. Through this case study, we provide a benchmark for short-term blood glucose prediction across all 10 publicly available diabetes datasets within the Glucose-ML collection. We show that the same algorithm can have significantly different prediction results when developed/evaluated with different datasets. Findings from this study are then used to inform recommendations for developing robust AI solutions within the diabetes or broader health domain. We provide direct links to each longitudinal diabetes dataset and openly provide our code.